>
Switch to:

Tekla Life Sciences Investors Total Equity

: $483.6 Mil (As of Sep. 2020)
View and export this data going back to . Start your Free Trial

Tekla Life Sciences Investors's total equity for the quarter that ended in Sep. 2020 was $483.6 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.


Tekla Life Sciences Investors Total Equity Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Tekla Life Sciences Investors Annual Data
Sep17 Sep18 Sep19 Sep20
Total Equity 466.35 475.49 383.65 483.57

Tekla Life Sciences Investors Semi-Annual Data
Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20
Total Equity Premium Member Only Premium Member Only 475.49 425.13 383.65 401.49 483.57

Tekla Life Sciences Investors Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Tekla Life Sciences Investors's Total Equity for the fiscal year that ended in Sep. 2020 is calculated as

Total Equity=Total Assets(Q: Sep. 2020 )-Total Liabilities(Q: Sep. 2020 )
=484.166-0.595
=483.6

Tekla Life Sciences Investors's Total Equity for the quarter that ended in Sep. 2020 is calculated as

Total Equity=Total Assets(Q: Sep. 2020 )-Total Liabilities(Q: Sep. 2020 )
=484.166-0.595
=483.6

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Tekla Life Sciences Investors Total Equity Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)